A randomized, double-blind, placebo-controlled, interleaved, ascending dose study, to evaluate safety, tolerability and pharmacokinetics of single oral doses of AQW051; to evaluate the effect of food on the pharmacokinetics of AQW051, in Japanese healthy male subjects

Trial Profile

A randomized, double-blind, placebo-controlled, interleaved, ascending dose study, to evaluate safety, tolerability and pharmacokinetics of single oral doses of AQW051; to evaluate the effect of food on the pharmacokinetics of AQW051, in Japanese healthy male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Oct 2013

At a glance

  • Drugs AQW 051 (Primary)
  • Indications Psychotic disorders
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 09 Oct 2013 Results presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.
    • 21 Jun 2007 Status change from in progress to completed
    • 30 Dec 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top